ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Acanthe Developpement

Acanthe Developpement (ACAN)

0.405
0.00
(0.00%)
Closed July 13 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.405
Bid
0.40
Ask
0.41
Volume
6,000
0.40 Day's Range 0.405
0.34 52 Week Range 0.498
Market Cap
Previous Close
0.405
Open
0.40
Last Trade
5000
@
0.405
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
21,054
Shares Outstanding
147,125,260
Dividend Yield
13.36%
PE Ratio
-5.03
Earnings Per Share (EPS)
-0.08
Revenue
3.6M
Net Profit
-11.71M

About Acanthe Developpement

Sector
Real Estate Dealers
Industry
Real Estate Dealers
Headquarters
Paris, Paris, Fra
Founded
1970
Acanthe Developpement is listed in the Real Estate Dealers sector of the Euronext with ticker ACAN. The last closing price for Acanthe Developpement was 0.41 €. Over the last year, Acanthe Developpement shares have traded in a share price range of 0.34 € to 0.498 €.

Acanthe Developpement currently has 147,125,260 shares outstanding. The market capitalization of Acanthe Developpement is 59.59 € million. Acanthe Developpement has a price to earnings ratio (PE ratio) of -5.03.

ACAN Latest News

Acanthe Développement : Communiqué de mise à disposition du rapport du conseil d'Administration sur le gouvernement d'entreprise

Acanthe Développement : Communiqué de mise à disposition du rapport du conseil d'Administration sur le gouvernement d'entreprise ACANTHE DEVELOPPEMENT Société Européenne au...

Acanthe Developpement : Communiqué de mise à disposition des documents préparatoires à l'assemblée générale du 14 juin 2024

Acanthe Developpement : Communiqué de mise à disposition des documents préparatoires à l'assemblée générale du 14 juin 2024 Acanthe Développement Société Européenne au capital de...

Acanthe Developpement : Communiqué sur la mise à disposition du rapport financier annuel 2023

Acanthe Developpement : Communiqué sur la mise à disposition du rapport financier annuel 2023 ACANTHE DEVELOPPEMENT Société Européenne au capital de 19 991 141 euros 55, rue Pierre Charron...

Acanthe Developpement : Communiqué sur les résultats annuels 2023

Acanthe Developpement : Communiqué sur les résultats annuels 2023       RESULTATS ANNUELS 2023 Paris, le 25 avril 2024 Patrimoine112,4 Millions d’euros Résultat net consolidé(Part du...

Acanthe Developpement : Communiqué relatif à la mise en paiement des dividendes

Acanthe Developpement : Communiqué relatif à la mise en paiement des dividendes Paris, le 13 octobre 2023 Communiqué relatif à la mise en paiement de la distribution exceptionnelle décidée...

Acanthe Developpement : Communiqué de mise à disposition du rapport financier semestriel

Acanthe Developpement : Communiqué de mise à disposition du rapport financier semestriel   55, rue Pierre Charron – 75008 PARIS – Tél : 01 56 52 45 00 – Fax : 01 53 23 10 11        ...

Acanthe Developpement : Communiqué sur les résultats semestriels au 30 juin 2023

Acanthe Developpement : Communiqué sur les résultats semestriels au 30 juin 2023 RESULTATS SEMESTRIELS 2023 Paris, le 28 septembre 2023 Patrimoine116,2 Millions d’euros Actif net...

Acanthe Developpement : Communiqué de mise à disposition des documents préparatoires à l'Assemblée Générale

Acanthe Developpement : Communiqué de mise à disposition des documents préparatoires à l'Assemblée Générale   Société Européenne au capital de 19 991 141 euros 55 rue Pierre Charron –...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0051.250.40.4150.389107730.41021918DE
4-0.003-0.7352941176470.4080.4250.389138220.40276396DE
120.0051.250.40.4360.381210540.40671887DE
260.0153.846153846150.390.4360.35178020.39787426DE
520.0359.459459459460.370.4980.34319840.40921333DE
156-0.003-0.7352941176470.4080.5460.34233650.41803467DE
260-0.105-20.58823529410.510.5460.337207250.42756603DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.65M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Discussion

View Full Feed
palaypu0406 palaypu0406 1 minute ago
Being a CPA and CA, myself, with 40 years of management experience, without contingency planning we never move an inch LVerstee...
For everything, we make plan A, Plan B, Plan c and Plan D...
ITUP
mike00h mike00h 3 minutes ago
I’ve heard that a lot of money is skimmed out of the OTC by market makers and more taken through spoofing and manipulation. Since they have no scruples do they try to influence regulatory authorities? Bribes? Blackmail? Influence? Big Pharma’s been doing that to US congress for decades, or so I’ve h
NWBO
Lykiri Lykiri 3 minutes ago
I think Owain James is the patient.

I'm so sorry to hear about the passing of Owain James.
https://x.com/FundsForOwain/status/1806963918201377111
NWBO
palaypu0406 palaypu0406 4 minutes ago
It is the other way round Lverstee...
We have been quite entrepreneurial ...
We never sought money from any outsider (not a single new investor) ...
Out time was our immeasurable investment more than what we took support from shareholders as cash...
In the millions of dol
ITUP
Seminole Red Seminole Red 4 minutes ago
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/450623386_122156120222136702_3891421874257498899_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=127cfc&_nc_ohc=v59L4AmuoO8Q7kNvgGsb92-&_nc_ht=scontent-mia3-2.xx&oh=00_AYA7hMC2vf3-nIgQ-fAo30hf-TxETlMmnapDy5Sgd-t5fQ&oe=6698C486
XenaLives XenaLives 4 minutes ago
It's been too long - see replied to post...

zebra2142

Re: None

Monday, January 30, 2023 11:07:43 AM

Post# 131857 of 196427
All you need to know about Kerrisdale Capital:

"The Department of Justice and the U.S. Securit
LWLG
Truthsocial Truthsocial 4 minutes ago
Exactly always a wench in the circle.....look at the FDA guidelines and don't read into abc.

Of course we knew the answer

Remember June 28th submitted following week was Holiday July 4th week which does not affect the 30 day calendar. So a logical analysis without thro
SMH
Sammy 967 Sammy 967 6 minutes ago
Question is how much is VAZKEPA is in China and most important question is how many people there can afford it.
AMRN
mattsinvestmentclub mattsinvestmentclub 6 minutes ago
Yes, waiting for updates after goldsteins "plaintiff" lawyers backed out for "unknown" reasons.
Plausible reasons include Goldstein lied about something.
could be they saw the evidence submitted by Omni/soloviev and realized Goldstein wasn't forth coming.
Could be something co
OMHE
Hopeforthefuture3 Hopeforthefuture3 8 minutes ago
Manibiotech, you are entirely correct. The 'paid pumpers' do not want to debate any facts or suggest what management could do better they just hurl insults. I believe in the science since I first read the 2011 paper by Prins and Liau but nwbo management imo needs to a better job of telling the story
NWBO
JMoneyHoops JMoneyHoops 8 minutes ago
Yep I definitely will be, nothing new since the May 14th court submission
BCAP
swamp boy swamp boy 8 minutes ago
I agree with glow on both points they are ALL guilty , we were taken by a bunch of thiefs .We need a lawyer!
ENZC
Nemesis18 Nemesis18 8 minutes ago
Thankyou for that information. It is very much appreciated. Regards.
NWBO
LVerstee LVerstee 8 minutes ago
I like contingencies. Especially one that has proven worth. Have you worked on that contingency?
ITUP
kayak_wench kayak_wench 9 minutes ago
Hurrah!! Monday July 29 is the date!! Only twoish weeks away!!!

Chat GPT agrees with everyone, so I am convinced.

The 30-day review period for the FDA to review an Investigational Device Exemption (IDE) and make a decision starts from the date the FDA receives the IDE
RDGL
GLee17 GLee17 9 minutes ago
That is cool. Looking forward to an update.
MVNT
fwb fwb 9 minutes ago
Alibaba Backs $2.5 Billion AI Firm in Second Big 2024 Deal
https://finance.yahoo.com/news/alibaba-backs-2-5-billion-065533653.html
BABA
Chiugray Chiugray 10 minutes ago
Ilovetch, Post approval, once the value is higher, financial equity investors can provide more substantive operating cash. BP can more appropriately provide technology and access opportunities. At that time, I believe raising cash from financial equity investors will be relatively cheaper (dilution)
NWBO
ipiros ipiros 10 minutes ago
Ethan is holding millions in his hands, he just has to make the right connections.
FUNR
SILVERSURFER4263 SILVERSURFER4263 10 minutes ago
Ault Lending, LLC a CONVICTED fing felon in bed with a future CONVICTED felon david michery....wake up SEC
MULN
Lime Time Lime Time 11 minutes ago
In all fairness, there haven't been many winning penny plays in the last 3 years. We were seeing 20B on a few tickers in 2021 daily. Now we are lucky to see 200m on the most active, if even that. The money is not there. That's why George is counting on 2025 to be a Banner Year here. It's been a horr
GVSI
StayHumble StayHumble 11 minutes ago
✅ $DBMM Clients:UCLA✅Xerox-Maybach-HR0wen-Savills-AbbeyRoadInstitute-Santander - Mercedes ✅✅✅ Chatsworth - Ernst&Young Omnisport - PinsentMasons


https://www.dbmmgroup.com/wp-content/uploads/2024/03/DBMM_Creds_Deck_2024_2.pdf

DBMM
tmcfo tmcfo 11 minutes ago
Have a safe trip most of all..
MVNT

Your Recent History

Delayed Upgrade Clock